Clinical Trial Update: Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a conditioning regimen of busulfan and etoposide followed by peripheral blood stem cell transplant with low-dose aldesleukin in adults …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Aldesleukin (interleukin-2)
• BUSULFAN (Busulfan)
• Etoposide (Etoposide)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 2 | Status: COMPLETED | Results posted: 2017-06-05